0000861878-15-000017.txt : 20150507 0000861878-15-000017.hdr.sgml : 20150507 20150507153112 ACCESSION NUMBER: 0000861878-15-000017 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 11 CONFORMED PERIOD OF REPORT: 20150331 FILED AS OF DATE: 20150507 DATE AS OF CHANGE: 20150507 FILER: COMPANY DATA: COMPANY CONFORMED NAME: STERICYCLE INC CENTRAL INDEX KEY: 0000861878 STANDARD INDUSTRIAL CLASSIFICATION: HAZARDOUS WASTE MANAGEMENT [4955] IRS NUMBER: 363640402 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-21229 FILM NUMBER: 15841351 BUSINESS ADDRESS: STREET 1: 28161 NORTH KEITH DRIVE STREET 2: - CITY: LAKE FOREST STATE: IL ZIP: 60045 BUSINESS PHONE: 8473675910 MAIL ADDRESS: STREET 1: 28161 NORTH KEITH DRIVE STREET 2: - CITY: LAKE FOREST STATE: IL ZIP: 60045 10-Q 1 srcl-20150331x10q.htm 10-Q SRCL-2015.03.31-10Q
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 10-Q
 
x     QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended March 31, 2015 or
¨     TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from             to             
Commission File Number 0-21229
 
Stericycle, Inc.
(Exact name of registrant as specified in its charter)
 
Delaware
 
36-3640402
(State or other jurisdiction of incorporation or organization)
 
(IRS Employer Identification Number)
28161 North Keith Drive
Lake Forest, Illinois 60045
(Address of principal executive offices, including zip code)
(847) 367-5910
(Registrant’s telephone number, including area code)
 
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15 (d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file reports), and (2) has been subject to such filing requirements for the past 90 days. YES x NO ¨
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). YES x NO ¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definition of "large accelerated filer”, "accelerated filer” and "smaller reporting company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer x
  
Accelerated filer ¨
Non-accelerated filer ¨
  
Smaller reporting company ¨
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). YES ¨ NO x
As of May 4, 2015 there were 85,047,014 shares of the registrant’s Common Stock outstanding.




Stericycle, Inc.
Table of Contents
 
 
Page No.
 
 
 
 
Condensed Consolidated Balance Sheets as of March 31, 2015 and December 31, 2014
 
 
Condensed Consolidated Statements of Income for the three months ended March 31, 2015 and 2014
 
 
Condensed Consolidated Statements of Comprehensive Income for the three months ended March 31, 2015 and 2014
 
 
Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 2015 and 2014
 
 
Condensed Consolidated Statements of Changes in Equity for the three months ended March 31, 2015 and year ended December 31, 2014
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 




PART I. – FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS
STERICYCLE, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(Unaudited)

In thousands, except share and per share data
 
March 31,
2015
 
December 31,
2014
ASSETS
 
 
 
Current Assets:
 
 
 
Cash and cash equivalents
$
38,283

 
$
22,236

Short-term investments
116

 
380

Accounts receivable, less allowance for doubtful accounts of $19,176 in 2015 and $19,083 in 2014
467,094

 
465,473

Deferred income taxes
27,331

 
28,322

Prepaid expenses
29,847

 
30,632

Other current assets
33,392

 
33,173

Total Current Assets
596,063

 
580,216

Property, Plant and Equipment, less accumulated depreciation of $374,115 in 2015 and $364,124 in 2014
446,831

 
460,408

Goodwill
2,419,284

 
2,418,832

Intangible assets, less accumulated amortization of $119,535 in 2015 and $114,922 in 2014
889,360

 
909,645

Other assets
31,976

 
32,621

Total Assets
$
4,383,514

 
$
4,401,722

LIABILITIES AND EQUITY
 
 
 
Current liabilities:
 
 
 
Current portion of long-term debt
$
113,212

 
$
131,969

Accounts payable
120,198

 
114,596

Accrued liabilities
157,047

 
131,743

Deferred revenues
20,313

 
21,624

Other current liabilities
71,630

 
61,599

Total Current Liabilities
482,400

 
461,531

Long-term debt, net of current portion
1,462,177

 
1,527,246

Deferred income taxes
422,971

 
431,643

Other liabilities
65,959

 
64,117

Equity:
 
 
 
Common stock (par value $.01 per share, 120,000,000 shares authorized, 85,208,191 issued and outstanding in 2015 and 84,883,517 issued and outstanding in 2014)
852

 
849

Additional paid-in capital
331,428

 
289,211

Accumulated other comprehensive loss
(206,434
)
 
(138,419
)
Retained earnings
1,805,059

 
1,743,371

Total Stericycle, Inc.’s Equity
1,930,905

 
1,895,012

Noncontrolling interest
19,102

 
22,173

Total Equity
1,950,007

 
1,917,185

Total Liabilities and Equity
$
4,383,514

 
$
4,401,722



The accompanying notes are an integral part of these condensed consolidated financial statements.

1


STERICYCLE, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(Unaudited)

In thousands, except share and per share data
 
Three Months Ended March 31,
 
2015
 
2014
Revenues
$
663,319

 
$
569,955

Costs and Expenses:
 
 
 
Cost of revenues (exclusive of depreciation shown below)
367,340

 
301,760

Depreciation - cost of revenues
14,648

 
12,726

Selling, general and administrative expenses (exclusive of depreciation and amortization shown below)
141,363

 
112,180

Depreciation – selling, general and administrative expenses
4,118

 
3,315

Amortization
8,797

 
7,315

Total Costs and Expenses
536,266

 
437,296

Income from Operations
127,053

 
132,659

Other Income (Expense):
 
 
 
Interest income
35

 
20

Interest expense
(18,633
)
 
(14,918
)
Other expense, net
(598
)
 
(700
)
Total Other Expense
(19,196
)
 
(15,598
)
Income Before Income Taxes
107,857

 
117,061

Income Tax Expense
32,047

 
37,291

Net Income
$
75,810

 
$
79,770

Less: Net Income Attributable to Noncontrolling Interests
352

 
621

Net Income Attributable to Stericycle, Inc.
$
75,458

 
$
79,149

Earnings Per Common Share Attributable to Stericycle, Inc. Common Shareholders:
 
 
 
Basic
$
0.89

 
$
0.93

Diluted
$
0.87

 
$
0.91

Weighted Average Number of Common Shares Outstanding:
 
 
 
Basic
85,037,823

 
85,270,046

Diluted
86,357,006

 
86,613,843



The accompanying notes are an integral part of these condensed consolidated financial statements.

2


STERICYCLE, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(Unaudited)

In thousands
 
Three Months Ended March 31,
 
2015
 
2014
Net Income
$
75,810

 
$
79,770


 
 
 
Other Comprehensive Income/ (Loss):
 
 
 
Foreign currency translation adjustments
(64,501
)
 
(1,109
)
Amortization of cash flow hedge into income, net of tax ($54 and $50) for the three months ended March 31, 2015 and 2014, respectively)
90

 
79

Change in fair value of cash flow hedge, net of tax ($2,381 and $0) for the three-months ended March 31, 2015 and 2014, respectively)
(4,424
)
 

     Total Other Comprehensive Income/ (Loss)
(68,835
)
 
(1,030
)

 
 
 
Comprehensive Income
6,975

 
78,740

Less: Comprehensive Income/ (Loss) Attributable to Noncontrolling Interests
(468
)
 
251

Comprehensive Income Attributable to Stericycle, Inc.
$
7,443

 
$
78,489



The accompanying notes are an integral part of these condensed consolidated financial statements.

3


STERICYCLE, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
In thousands
  
Three Months Ended March 31,
 
2015
 
2014
OPERATING ACTIVITIES:
 
 
 
Net income
$
75,810

 
$
79,770

Adjustments to reconcile net income to net cash provided by operating activities:
 
 
 
Stock compensation expense
5,487

 
4,672

Excess tax benefit of stock options exercised
(8,222
)
 
(3,734
)
Depreciation
18,766

 
16,041

Amortization
8,797

 
7,315

Deferred income taxes
(2,957
)
 
6,175

Change in fair value of contingent consideration
(675
)
 
4,789

Other, net
5,988

 

Changes in operating assets and liabilities, net of effect of acquisitions and divestitures:
 
 
 
Accounts receivable
(14,491
)
 
4,529

Accounts payable
5,443

 
5,279

Accrued liabilities
35,924

 
14,189

Deferred revenues
(628
)
 
2,642

Other assets and liabilities
3,312

 
4,182

Net cash provided by operating activities
132,554

 
145,849

INVESTING ACTIVITIES:
 
 
 
Payments for acquisitions, net of cash acquired
(34,210
)
 
(12,262
)
Proceeds from/ (purchases of) investments
257

 
(1,947
)
Capital expenditures
(21,356
)
 
(16,420
)
Net cash used in investing activities
(55,309
)
 
(30,629
)
FINANCING ACTIVITIES:
 
 
 
Repayments of long-term debt and other obligations
(9,780
)
 
(12,430
)
Borrowings on foreign bank debt
4,851

 
36,640

Repayments on foreign bank debt
(38,252
)
 
(37,157
)
Borrowings on term loan
250,000

 

Borrowings on senior credit facility
394,097

 
149,000

Repayments on senior credit facility
(670,254
)
 
(203,377
)
Payments on capital lease obligations
(988
)
 
(876
)
Purchases and cancellations of treasury stock
(11,516
)
 
(76,914
)
Payment for cash flow hedge
(8,833
)
 

Proceeds from issuance of common stock
27,452

 
8,655

Excess tax benefit of stock options exercised
8,222

 
3,734

Payments to noncontrolling interests
(2,603
)
 
(97
)
Net cash used in financing activities
(57,604
)
 
(132,822
)
Effect of exchange rate changes on cash and cash equivalents
(3,594
)
 
43

Net increase/ (decrease) in cash and cash equivalents
16,047

 
(17,559
)
Cash and cash equivalents at beginning of period
22,236

 
67,167

Cash and cash equivalents at end of period
$
38,283

 
$
49,608


 
 
 
NON-CASH ACTIVITIES:
 
 
 
Issuances of obligations for acquisitions
$
21,543

 
$
13,095



The accompanying notes are an integral part of these condensed consolidated financial statements.

4


STERICYCLE, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY
Three Months Ended March 31, 2015 and
Year Ended December 31, 2014
(Unaudited)

In thousands
 
Stericycle, Inc. Equity
 
 
 
 
 
Issued
and
Outstanding
Shares
 
Common
Stock
 
Additional
Paid-In
Capital
 
Retained
Earnings
 
Accumulated Other
Comprehensive
Income (Loss)
 
Noncontrolling
Interest
 
Total Equity
Balance at January 1, 2014
85,500

 
$
855

 
$
195,110

 
$
1,610,964

 
$
(56,468
)
 
$
17,077

 
$
1,767,538

Net income
 
 
 
 
 
 
326,456

 
 
 
1,690

 
328,146

Currency translation adjustment
 
 
 
 
 
 
 
 
(80,221
)
 
(2,650
)
 
(82,871
)
Change in qualifying cash flow hedge, net of tax
 
 
 
 
 
 
 
 
(1,730
)
 
 
 
(1,730
)
Issuance of common stock for exercise of options, restricted stock units and employee stock purchases
1,061

 
11

 
58,551

 
 
 
 
 
 
 
58,562

Purchase/ cancellation of treasury stock
(1,677
)
 
(17
)
 

 
(194,049
)
 
 
 
 
 
(194,066
)
Stock compensation expense
 
 
 
 
17,773

 
 
 
 
 
 
 
17,773

Excess tax benefit of stock options exercised
 
 
 
 
17,906

 
 
 
 
 
 
 
17,906

Noncontrolling interests attributable to acquisitions
 
 
 
 
 
 
 
 
 
 
6,781

 
6,781

Reduction to noncontrolling interests due to additional ownership
 
 
 
 
(129
)
 
 
 
 
 
(725
)
 
(854
)
Balance at December 31, 2014
84,884

 
$
849

 
$
289,211

 
$
1,743,371

 
$
(138,419
)
 
$
22,173

 
$
1,917,185

Net income
 
 
 
 
 
 
75,458

 
 
 
352

 
75,810

Currency translation adjustment
 
 
 
 
 
 
 
 
(63,681
)
 
(820
)
 
(64,501
)
Change in qualifying cash flow hedge, net of tax
 
 
 
 
 
 
 
 
(4,334
)
 
 
 
(4,334
)
Issuance of common stock for exercise of options, restricted stock units and employee stock purchases
425

 
4

 
28,508

 
 
 
 
 
 
 
28,512

Purchase/ cancellation of treasury stock
(101
)
 
(1
)
 

 
(13,770
)
 
 
 
 
 
(13,771
)
Stock compensation expense
 
 
 
 
5,487

 
 
 
 
 
 
 
5,487

Excess tax benefit of stock options exercised
 
 
 
 
8,222

 
 
 
 
 
 
 
8,222

Reduction to noncontrolling interests due to additional ownership
 
 
 
 

 
 
 
 
 
(2,603
)
 
(2,603
)
Balance at March 31, 2015
85,208

 
$
852

 
$
331,428

 
$
1,805,059

 
$
(206,434
)
 
$
19,102

 
$
1,950,007



The accompanying notes are an integral part of these condensed consolidated financial statements.

5


STERICYCLE, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
Unless the context requires otherwise, "we", "us" or "our" refers to Stericycle, Inc. and its subsidiaries on a consolidated basis.
NOTE 1 – BASIS OF PRESENTATION
The accompanying condensed consolidated financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission. Certain information and footnote disclosures normally included in annual consolidated financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to such rules and regulations. However, the Company believes the disclosures included in the accompanying condensed consolidated financial statements are adequate to make the information presented not misleading. In our opinion, all adjustments necessary for a fair presentation for the periods presented have been reflected and are of a normal recurring nature. These condensed consolidated financial statements should be read in conjunction with the Stericycle, Inc. and Subsidiaries Consolidated Financial Statements and notes thereto for the year ended December 31, 2014, as filed with our Annual Report on Form 10-K for the year ended December 31, 2014. The results of operations for the three months ended March 31, 2015 are not necessarily indicative of the results that may be achieved for the entire year ending December 31, 2015.
There were no material changes in the Company’s critical accounting policies since the filing of its 2014 Form 10-K. As discussed in the 2014 Form 10-K, the preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States requires management to make certain estimates and assumptions that affect the amount of reported assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and revenues and expenses during the periods reported. Actual results may differ from those estimates.
We have evaluated subsequent events through the date of filing this quarterly report on Form 10-Q. No events have occurred that would require adjustment to or disclosure in the condensed consolidated financial statements.
NOTE 2 – ACQUISITIONS AND DIVESTITURES
The following table summarizes the locations of our acquisitions for the three months ended March 31, 2015:
Acquisition Locations
 
2015
United States
 
4

Brazil
 
2

Ireland
 
1

Mexico
 
2

Romania
 
2

Republic of Korea
 
3

Spain
 
1

Total
 
15

During the quarter ended March 31, 2015, we completed fifteen acquisitions. Domestically, we acquired 100% of stock of one regulated waste business and selected assets of three regulated waste

6


businesses. Internationally, in Brazil, we acquired 100% of the stock of two regulated waste businesses. In Ireland, we acquired 100% of the stock of one regulated waste business. In Mexico, we acquired 100% of the stock of two regulated waste businesses. In Romania, we acquired selected assets of two regulated waste businesses. In Republic of Korea, we acquired selected assets of three regulated waste businesses. In Spain, we acquired selected assets of one regulated waste business.
The following table summarizes the aggregate purchase price paid for acquisitions and other adjustments of consideration to be paid for acquisitions during the three months ended March 31:
In thousands
 
Three Months Ended March 31,
 
2015
 
2014
Cash
$
34,210

 
$
12,262

Promissory notes
7,618

 
12,654

Deferred consideration
624

 
441

Contingent consideration
13,301

 

Total purchase price
$
55,753

 
$
25,357

For financial reporting purposes, our acquisitions were accounted for using the acquisition method of accounting. These acquisitions resulted in the recognition of goodwill in our financial statements reflecting the premium paid to acquire businesses that we believe are complementary to our existing operations and fit our growth strategy. During the three months ended March 31, 2015, we recognized a net increase in goodwill of $41.2 million excluding the effect of foreign currency translation (see Note 9 – Goodwill and Other Intangible Assets, in the Notes to the Condensed Consolidated Financial Statements). A net increase of $12.2 million was assigned to our United States reportable segment, and a net increase of $29.0 million was assigned to our International reportable segment. Approximately $6 million of the goodwill recognized during the three months ended March 31, 2015 will be deductible for income taxes.
During the three months ended March 31, 2015, we recognized a net increase of $19.8 million from the estimated fair value of acquired customer relationships, excluding the effect of foreign currency translation. Amortizable lives of the acquired during the quarter customer relationships ranges 15 to 20 years.
The purchase prices for these acquisitions in excess of acquired tangible assets have been primarily allocated to goodwill and other intangibles and are preliminary, pending completion of certain intangible asset valuations and completion accounts. The following table summarizes the preliminary purchase price allocation for current period acquisitions and other adjustments to purchase price allocations during the three months ended March 31:
In thousands
 
Three Months Ended March 31,
 
2015
 
2014
Fixed assets
$
(1,477
)
 
$
1,184

Intangibles
19,791

 
14,277

Goodwill
41,190

 
10,850

Accounts receivable
4,217

 
2,223

Accounts payable
(3,512
)
 
(659
)
Net other (liabilities)/ assets
(1,079
)
 
(2,024
)
Debt

 
321

Net deferred tax liabilities
(3,377
)
 
(815
)
Total purchase price allocation
$
55,753

 
$
25,357



7


During the three months ended March 31, 2015 and 2014, the Company incurred $3.3 million and $3.2 million, respectively, of acquisition related expenses. These expenses are included with "Selling, general and administrative expenses" ("SG&A") on our Condensed Consolidated Statements of Income.

NOTE 3 – NEW ACCOUNTING STANDARDS

Accounting Standards Recently Adopted
Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity
On January 1, 2015, we adopted guidance on the presentation and disclosures of reporting discontinued operations. The new guidance defines a discontinued operation as a disposal of a component or group of components that is disposed of or is classified as held for sale and "represents a strategic shift that has (or will have) a major effect on an entity's operations and financial results." For disposals of individually significant components that do not qualify as discontinued operations, an entity must disclose pre-tax earnings of the disposed component. The Company has not disposed of a component of our entity and therefore the implementation of this guidance did not affect our financial position, results of operations, or disclosure requirements.

Accounting Standards Issued But Not Yet Adopted
Revenue From Contracts With Customers
In May 2014, the Financial Accounting Standards Board (the "FASB") issued guidance to provide a single, comprehensive revenue recognition model for all contracts with customers. The revenue guidance contains principles that an entity will apply to determine the measurement of revenue and timing of when it is recognized. The underlying principle is that an entity will recognize revenue to depict the transfer of goods or services to customers at an amount that the entity expects to be entitled to in exchange for those goods or services. The standard will be effective for the first interim period within annual reporting periods beginning after December 15, 2016 for public entities, with no early adoption permitted. The Company is currently evaluating the impact of the change, however it does not expect the adoption of this guidance to have a material impact on the Company’s financial position or results of operations.
On April 1, 2015, the FASB voted to propose to defer the effective date of the new revenue recognition standard by one year; although early adoption will be permitted after January 1, 2017. The FASB expects to issue an Accounting Standards Update for public comment during the second quarter of 2015.

Accounting for Share-Based Payment When the Terms of an Award Provide That a Performance Target Could Be Achieved After the Requisite Service Period
In June 2014, the FASB issued guidance that applies to all reporting entities that grant their employees share-based payments in which the terms of the award provide that a performance target that affects vesting could be achieved after the requisite service period. It requires that a performance target that affects vesting and that could be achieved after the requisite service period be treated as a performance condition and follows existing accounting guidance for the treatment of performance conditions. The standard will be effective for annual periods and interim periods within those annual periods beginning after December 15, 2015, with early adoption permitted. The Company does not have any share-based payments with a performance target and therefore does not expect the adoption of this guidance to have a material impact on the Company’s financial position or results of operations.


8


Interest-Imputation of Interest
In April 2015, the FASB issued guidance that requires debt issuance costs related to a recognized debt liability to be presented in the balance sheet as a direct deduction from the debt liability rather than as an asset. The recognition and measurement guidance for debt issuance costs are not affected by the accounting standard update. The standard will be effective for annual periods and interim periods within those annual periods beginning after December 15, 2015, with early adoption permitted. The revised standard will be adopted by the Company on January 1, 2016, will be applied retrospectively and will require reclassifications within the Company’s consolidated balance sheets and statements of cash flows.  The revised standard only affects presentation and therefore will not have an impact on the Company’s results of operations.
NOTE 4 – FAIR VALUE MEASUREMENTS
Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The fair value hierarchy distinguishes between (1) market participant assumptions developed based on market data obtained from independent sources (observable inputs) and (2) an entity's own assumptions about market participant assumptions developed based on the best information available in the circumstances (unobservable inputs). The fair value hierarchy consists of three broad levels, which gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The three levels of the fair value hierarchy are described below:
Level 1 – Quoted prices in active markets for identical assets or liabilities.
Level 2 – Observable inputs other than quoted prices in active markets for identical assets and liabilities, quoted prices for identical or similar assets or liabilities in inactive markets, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
Level 3 – Inputs that are generally unobservable and typically reflect management’s estimate of assumptions that market participants would use in pricing the asset or liability.
Financial assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. Our assessment of the significance of a particular input to the fair value measurement requires judgment, and may affect the valuation of assets and liabilities and their placement within the fair value hierarchy levels. The impact of our creditworthiness has been considered in the fair value measurements noted below. In addition, the fair value measurement of a liability must reflect the nonperformance risk of an entity. There were no movements of items between fair value hierarchies.
In thousands
 
 
 
Fair Value Measurements Using
 
Total as of
March 31, 2015
 
Level 1
Inputs
 
Level 2
Inputs
 
Level 3
Inputs
Assets:
 
 
 
 
 
 
 
Cash and cash equivalents
$
38,283

 
$
38,283

 
$

 
$

Short-term investments
116

 
116

 

 

Derivatives financial instruments
1,057

 

 
1,057

 

Total assets
$
39,456

 
$
38,399

 
$
1,057

 
$

Liabilities:
 
 
 
 
 
 
 
Contingent consideration
$
28,423

 
$

 
$

 
$
28,423

Total liabilities
$
28,423

 
$

 
$

 
$
28,423


9


In thousands
 
 
 
Fair Value Measurements Using
 
Total as of
December 31, 2014
 
Level 1
Inputs
 
Level 2
Inputs
 
Level 3
Inputs
Assets:
 
 
 
 
 
 
 
Cash and cash equivalents
$
22,236

 
$
22,236

 
$

 
$

Short-term investments
380

 
380

 

 

Derivatives financial instruments
515

 

 
515

 

Total assets
$
23,131

 
$
22,616

 
$
515

 
$

Liabilities:
 
 
 
 
 
 
 
Contingent consideration
$
19,941

 
$

 
$

 
$
19,941

Derivatives financial instruments
2,408

 

 
2,408

 

Total liabilities
$
22,349

 
$

 
$
2,408

 
$
19,941

For our derivative financial instruments we use a market approach valuation technique based on observable market transactions of spot and forward rates.
We recorded a $1.1 million asset related to the fair value of the U.S. dollar-Canadian dollar foreign currency swap which was classified as other assets at March 31, 2015. The objective of the swap is to offset the foreign exchange risk to the U.S. dollar equivalent cash outflows for our Canadian subsidiary.
In March 2015, we cash settled a treasury lock hedge for $8.8 million of which $5.3 million, net of $3.5 million tax, was recognized in accumulated other comprehensive income. The purpose was to lock in the treasury rate on the issuance of expected private placement debt and to eliminate interest rate risk.
We had contingent consideration liabilities recorded using Level 3 inputs in the amount of $28.4 million, of which $17.2 million was classified as current liabilities at March 31, 2015. Contingent consideration liabilities were $19.9 million at December 31, 2014. Contingent consideration represents amounts expected to be paid as part of acquisition consideration only if certain future events occur. These events are usually targets for revenues or earnings related to the business acquired. We arrive at the fair value of contingent consideration by applying a weighted probability of potential outcomes to the maximum possible payout. The calculation of these potential outcomes is dependent on both past financial performance and management assumptions about future performance. If the financial performance measures were all fully met, our maximum liability would be $29.6 million at March 31, 2015. Contingent consideration liabilities are reassessed each quarter and are reflected in the Condensed Consolidated Balance Sheets as part of "Other current liabilities" and "Other liabilities". Changes to contingent consideration are reflected in the table below:
In thousands
Contingent consideration at December 31, 2014
 
$
19,941

Increases due to acquisitions
 
13,301

Decrease due to payments
 
(750
)
Changes due to foreign currency fluctuations
 
(3,394
)
Changes in fair value reflected in Selling, general, and administrative expenses
 
(675
)
Contingent consideration at March 31, 2015
 
$
28,423

Fair Value of Debt: At March 31, 2015, the fair value of the Company’s debt obligations was estimated, using Level 2 inputs, at $1.61 billion compared to a carrying amount of $1.58 billion. At December 31, 2014, the fair value of the Company’s debt obligations was estimated, using Level 2 inputs, at $1.67 billion compared to a carrying amount of $1.66 billion. The fair values were estimated using an income approach by applying market interest rates for comparable instruments. The Company has no current plans to retire a significant amount of its debt prior to maturity.

10


NOTE 5 – INCOME TAXES
We file income tax returns in the U.S, in various states and in certain foreign jurisdictions.
The Company has recorded accruals to cover uncertain tax positions taken on previously filed tax returns. Such liabilities relate to additional taxes, interest and penalties the Company may be required to pay in various tax jurisdictions. During the course of examinations by various taxing authorities, proposed adjustments may be asserted. The Company evaluates such items on a case-by-case basis and adjusts the accrual for uncertain tax positions. During the quarter ended March 31, 2015, we had no material changes to our accruals related to previous  or current uncertain tax positions. The effective tax rates for the quarters ended March 31, 2015 and 2014 were approximately 29.7% and 31.9%, respectively. The decrease in the current quarter tax rate is primarily related to a benefit from the recognition of tax deductible goodwill associated with legal entity mergers in Spain and Brazil.
NOTE 6 – STOCK BASED COMPENSATION
At March 31, 2015, we had the following stock option and stock purchase plans:

the 2014 Incentive Stock Plan, which our stockholders approved in May 2014;
the 2011 Incentive Stock Plan, which our stockholders approved in May 2011;
the 2008 Incentive Stock Plan, which our stockholders approved in May 2008;
the 2005 Incentive Stock Plan, which our stockholders approved in April 2005;
the 2000 Nonstatutory Stock Option Plan, which expired in February 2010;
the 1997 Stock Option Plan, which expired in January 2007;
the 1996 Directors Stock Option Plan, which expired in May 2006; and
the Employee Stock Purchase Plan ("ESPP"), which our stockholders approved in May 2001.
Stock-Based Compensation Expense:
The following table presents the total stock-based compensation expense resulting from stock option awards, restricted stock units ("RSUs"), and the ESPP included in the Condensed Consolidated Statements of Income:
In thousands
 
 
Three Months Ended March 31,
 
 
2015
 
2014
Cost of revenues – stock option plan
 
$
23

 
$
7

Selling, general and administrative – stock option plan
 
4,729

 
4,041

Selling, general and administrative – RSUs
 
346

 
315

Selling, general and administrative – ESPP
 
389

 
309

Total pre-tax expense
 
$
5,487

 
$
4,672

    
    

11


The following table sets forth the tax benefits related to stock compensation:
In thousands
 
 
Three Months Ended March 31,
 
 
2015
 
2014
Tax benefit recognized in Statement of Income
 
$
2,468

 
$
909

Excess tax benefit realized
 
8,222

 
3,734


Stock Options:

Stock option activity for the three months ended March 31, 2015, is summarized as follows:
 
 
Number of
Options
 
Weighted
Average
Exercise
Price per
Share
 
Weighted Average Remaining Contractual Life
 
Total Aggregate Intrinsic Value
 
 
 
 
 
 
(in years)
 
(in thousands)
Outstanding at beginning of year
 
5,377,857

 
$
80.88

 
 
 
 
Granted
 
860,534

 
130.33

 
 
 
 
Exercised
 
(425,175
)
 
65.19

 
 
 
 
Forfeited
 
(66,154
)
 
105.30

 
 
 
 
Canceled or expired
 
(1,100
)
 
56.90

 
 
 
 
Outstanding at March 31, 2015
 
5,745,962

 
$
89.17

 
6.27
 
$
294,519

Exercisable at March 31, 2015
 
3,133,658

 
$
71.77

 
5.37
 
$
215,171

Vested and expected to vest at March 31, 2015
 
5,476,973

 
$
87.92

 
 
 
 

As of March 31, 2015, there was $42.5 million of total unrecognized compensation expense related to non-vested option awards, which is expected to be recognized over a weighted average period of 3.48 years.
The following table sets forth the total intrinsic value of options exercised in the quarter ended March 31:
In thousands
 
 
Three Months Ended March 31,
 
 
2015
 
2014
Total exercise intrinsic value of options exercised
 
$
29,525

 
$
11,796


The total exercise intrinsic value represents the total pre-tax value (the difference between the sales price on that trading day the option was exercised and the exercise price associated with the respective option).

The Company uses historical data to estimate expected life and volatility. The estimated fair value of stock options at the time of the grant using the Black-Scholes model option pricing model was as follows:

12


 
 
Three Months Ended March 31,
 
 
2015
 
2014
Stock options granted (shares)
 
860,534

 
854,778

Weighted average fair value at grant date (per share)
 
$
22.84

 
$
21.28

Assumptions:
 
 
 
 
Expected term (in years)
 
4.79

 
4.78

Expected volatility
 
16.62
%
 
17.68
%
Expected dividend yield
 
%
 
%
Risk free interest rate
 
1.48
%
 
1.45
%
Restricted Stock Units:
Restricted stock units ("RSUs") vest at the end of three or five years. Our 2008, 2011 and 2014 Plans include a share reserve related to RSUs granted at a 2-1 ratio. A summary of the status of our non-vested RSUs and changes during the three months ended March 31, 2015, are as follows:
 
 
Number of
Units
 
Weighted Average Grant Date Fair Value
 
Total Aggregate Intrinsic Value
 
 
 
 
 
 
(in thousands)
Non-vested at beginning of year
 
63,600

 
$
96.04

 
 
Granted
 
10,124

 
130.19

 
 
Vested and released
 

 

 
 
Forfeited
 
(1,470
)
 
100.77

 
 
Non-vested at March 31, 2015
 
72,254

 
$
100.73

 
$
10,147


As of March 31, 2015, there was $5.0 million of total unrecognized compensation expense related to RSUs, which is expected to be recognized over a weighted average period of 2.92 years.
NOTE 7 – COMMON STOCK
The following table provides information about our repurchase of shares of our common stock during the three months ended March 31, 2015:
 
 
Number of
Shares
Repurchased
and
Canceled
 
Amount for
Repurchases
 
Average
Price Paid
per Share
 
 
 
 
(in thousands)

 
 
Three months ended March 31, 2015
 
100,713

 
$
13,771

 
$
136.74

 
 
 
 
 
 
 
Three months ended March 31, 2014
 
685,900

 
$
78,340

 
$
114.20


Of the 100,713 shares repurchased during the three months ended March 31, 2015, 16,000 shares in the amount of $2.3 million were not settled. This amount is recognized as part of other current liabilities on our Condensed Consolidated Balance Sheet at March 31, 2015.

13


NOTE 8 – EARNINGS PER COMMON SHARE
Basic earnings per share is computed by dividing income available to common shareholders by the weighted-average number of shares of common stock outstanding during the period. Diluted earnings per share is computed by dividing income available to common shareholders by the weighted-average number of shares of common stock outstanding during the period increased to include the number of additional shares of common stock that would have been outstanding if the potentially dilutive securities had been issued. Potentially dilutive securities include outstanding stock options, shares to be purchased under the Company’s employee stock purchase plan and RSUs. The effect of potentially dilutive securities is reflected in diluted earnings per share by application of the treasury stock method. Under the treasury stock method, an increase in the fair market value of the Company’s common stock can result in a greater dilutive effect from potentially dilutive securities.
The following table sets forth the computation of basic and diluted earnings per share:
In thousands, except share and per share data
 
 
Three Months Ended March 31,
 
 
2015
 
2014
Numerator:
 
 
 
 
Numerator for basic earnings per share net income attributable to Stericycle, Inc.
 
$
75,458

 
$
79,149

Denominator:
 
 
 
 
Denominator for basic earnings per share-weighted average shares
 
85,037,823

 
85,270,046

Effect of diluted securities:
 

 
 
Employee stock options
 
1,319,183

 
1,343,797

Denominator for diluted earnings per share-adjusted weighted average shares and after assumed exercises
 
86,357,006

 
86,613,843

Earnings per share – Basic
 
$
0.89

 
$
0.93

Earnings per share – Diluted
 
$
0.87

 
$
0.91

For additional information regarding outstanding employee stock options, see Note 6 - Stock Based Compensation, in the Notes to the Condensed Consolidated Financial Statements.

NOTE 9 – GOODWILL AND OTHER INTANGIBLE ASSETS
Goodwill and other identifiable indefinite lived intangibles are not amortized, but are subject to an annual impairment test, or more frequent testing if circumstances indicate that they may be impaired.
Goodwill:
We have two geographical reportable segments, "United States" and "International", both of which have goodwill. We have retroactively reclassified $6.4 million of goodwill related to Puerto Rico from the United States segment to the International segment. The changes in the carrying amount of goodwill since January 1, 2014, by reportable segment, were as follows:

14


In thousands
 
 
United States
 
International
 
Total
Balance as of January 1, 2014
 
$
1,671,723

 
$
559,859

 
$
2,231,582

Goodwill acquired during year
 
169,754

 
88,263

 
258,017

Purchase accounting allocation adjustments
 
(4,825
)
 
(17,595
)
 
(22,420
)
Changes due to foreign currency fluctuations
 
(2,337
)
 
(46,010
)
 
(48,347
)
Balance as of December 31, 2014
 
1,834,315

 
584,517

 
2,418,832

Goodwill acquired during year
 
10,260

 
28,989

 
39,249

Purchase accounting allocation adjustments
 
1,941

 

 
1,941

Goodwill other changes
 

 
(440
)
 
(440
)
Changes due to foreign currency fluctuations
 
(2,631
)
 
(37,667
)
 
(40,298
)
Balance as of March 31, 2015
 
$
1,843,885

 
$
575,399

 
$
2,419,284

Current year adjustments to goodwill for certain 2014 acquisitions are primarily due to the finalization of intangible asset valuations.
Other Intangible Assets:
As of March 31, 2015 and December 31, 2014, the values of other intangible assets were as follows:
In thousands
 
March 31, 2015
 
December 31, 2014
 
Gross
Carrying
Amount
 
Accumulated
Amortization
 
Net
Value
 
Gross
Carrying
Amount
 
Accumulated
Amortization
 
Net
Value
Amortizable intangibles:
 
 
 
 
 
 
 
 
 
 
 
Covenants not-to-compete
$
8,451

 
$
5,959

 
$
2,492

 
$
8,474

 
$
5,688

 
$
2,786

Customer relationships
750,022

 
112,107

 
637,915

 
755,148

 
107,365

 
647,783

Tradenames
4,265

 
880

 
3,385

 
6,062

 
1,313

 
4,749

Technology
611

 
547

 
64

 
611

 
521

 
90

Other
517

 
42

 
475

 
539

 
35

 
504

Indefinite lived intangibles:
 
 
 
 
 
 
 
 
 
 
 
Operating permits
239,229

 

 
239,229

 
247,933

 

 
247,933

Tradenames
5,800

 

 
5,800

 
5,800

 

 
5,800

Total
$
1,008,895

 
$
119,535

 
$
889,360

 
$
1,024,567

 
$
114,922

 
$
909,645

During the quarter ended March 31, 2015, we wrote off $0.2 million in customer relationships, $1.2 million in operating permits, and $1.0 million in tradenames, due to rationalizing certain of our domestic and international operations (see Note 13 - Restructuring Charges in the Notes to the Condensed Consolidated Financial Statements). These expenses are reflected as part of SG&A on our Condensed Consolidated Statements of Income. Under generally accepted accounting principles, a fair value must be assigned to all acquired assets based on a theoretical "market participant" regardless of the acquirer's intended use for those assets.This accounting treatment can lead to the recognition of losses when a company disposes of acquired assets. We complete our annual impairment analysis of our indefinite lived intangibles during the quarter ended December 31 of each year, or more frequently, if circumstances indicate that they may be impaired.
Our finite-lived intangible assets are amortized over their useful lives. We have determined that our customer relationships have useful lives from 10 to 40 years based upon the type of customer, with a weighted average remaining useful life of 23.6 years. We have covenants not-to-compete intangibles with useful lives from 3 to 14 years, with a weighted average remaining useful life of 4.4 years. We have tradename intangibles with useful lives from 10 to 40 years, with a weighted average remaining useful life of 17.3 years. We have technology with a useful life of 5 years, with a weighted average remaining useful life of 1.0 years. We have

15


determined that our permits have indefinite lives due to our ability to renew these permits with minimal additional cost, and therefore these are not amortized.
During the quarters ended March 31, 2015 and 2014, the aggregate amortization expense was $8.8 million and $7.3 million, respectively.
The estimated amortization expense for each of the next five years, assuming no additional amortizable intangible assets, is as follows for the years ended December 31:
In thousands
2015
 
$
34,084

2016
 
33,788

2017
 
33,662

2018
 
33,624

2019
 
33,603

Future amortization expense may fluctuate depending on changes in foreign currency rates, future acquisitions, or changes to the estimated amortizable life of the intangibles. The estimates for amortization expense noted above are based upon foreign exchange rates as of March 31, 2015.
NOTE 10 – ENVIRONMENTAL REMEDIATION LIABILITIES
We record a liability for environmental remediation when such liability becomes probable and the costs or damages can be reasonably estimated. We accrue environmental remediation costs, on an undiscounted basis, associated with identified sites where an assessment has indicated that cleanup costs are probable and can be reasonably estimated, but the timing of such payments is not fixed and determinable. Such accruals are based on currently available information, estimated timing of remedial actions, existing technology, and enacted laws and regulations. The liability for environmental remediation is included in the Consolidated Balance Sheets in current liabilities within "Accrued liabilities" and in noncurrent liabilities within "Other liabilities."
At March 31, 2015, the total environmental remediation liabilities recorded were $32.5 million, of which $3.2 million was classified as accrued liabilities and $29.3 million was classified as other liabilities.

16


NOTE 11 – DEBT
Long-term debt consisted of the following:
In thousands
 
 
March 31,
2015
 
December 31,
2014
Obligations under capital leases
 
$
7,427

 
$
9,185

$1.2 billion senior credit facility weighted average rate 1.72%, due in 2019
 
175,564

 
459,975

$250 million term loan 0.92%, due in 2015
 
250,000

 

$100 million private placement notes 5.64%, due in 2015
 
100,000

 
100,000

$175 million private placement notes 3.89%, due in 2017
 
175,000

 
175,000

$125 million private placement notes 2.68%, due in 2019
 
125,000

 
125,000

$225 million private placement notes 4.47%, due in 2020
 
225,000

 
225,000

$125 million private placement notes 3.26%, due in 2022
 
125,000

 
125,000

Promissory notes and deferred consideration weighted average rate of 3.92% and weighted average maturity of 3.3 years
 
274,804

 
279,590

Foreign bank debt weighted average rate 8.98% and weighted average maturity of 1.8 years
 
117,594

 
160,465

Total debt
 
1,575,389

 
1,659,215

Less: current portion of total debt
 
113,212

 
131,969

Long-term portion of total debt
 
$
1,462,177

 
$
1,527,246

Our $1.2 billion senior credit facility maturing in June 2019, our $250.0 million term loan maturing in July 2015, our $100.0 million private placement notes maturing April 2015, our $175.0 million private placement notes maturing in October 2017, our $125.0 million private placement notes maturing in December 2019, our $225.0 million private placement notes maturing in October 2020, and our $125.0 million private placement notes maturing in December 2022, all require us to comply with various financial, reporting and other covenants and restrictions, including a restriction on dividend payments. The financial debt covenants are the same for the senior credit facility and the private placement notes. At March 31, 2015, we were in compliance with all of our financial debt covenants.
As of March 31, 2015 and December 31, 2014, we had $157.7 million and $162.9 million, respectively, committed to outstanding letters of credit under our senior credit facility. The unused portion of the revolving credit facility as of March 31, 2015 and December 31, 2014 was $866.7 million and $577.1 million, respectively.
Both our $100.0 million private placement notes that mature in April 2015 and our $250.0 million term loan that matures in July 2015 were classified as long-term debt due to our intent and ability to refinance these obligations by using other senior credit facility.
NOTE 12 – GEOGRAPHIC INFORMATION
Management has determined that we have two reportable segments: United States and International. Revenues are attributed to countries based on the location of customers. The same accounting principles and critical accounting policies are used in the preparation of the financial statements for both reportable segments.
We have retroactively reclassified immaterial amounts related to Puerto Rico from the United States segment to the International segment.

17


Detailed information for our United States reportable segment is as follows:
In thousands
 
 
Three Months Ended March 31,
 
 
2015
 
2014
Regulated and compliance solutions revenues
 
$
452,269

 
$
366,699

Recall and returns solutions revenues
 
19,979

 
23,064

Total revenues
 
472,248

 
389,763

Net interest expense
 
10,845

 
10,646

Income before income taxes
 
102,890

 
104,492

Income taxes
 
37,880

 
37,039

Net income attributable to Stericycle, Inc.
 
$
65,010

 
$
67,453

 
 
 
 
 
Depreciation and amortization
 
$
16,140

 
$
12,697


Detailed information for our International reportable segment is as follows:
In thousands
 
 
Three Months Ended March 31,
 
 
2015
 
2014
Regulated and compliance solutions revenues
 
$
191,071

 
$
180,192

Net interest expense
 
7,753

 
4,252

Income before income taxes
 
4,967

 
12,569

Income taxes
 
(5,833
)
 
252

Net income
 
10,800

 
12,317

Less: net income attributable to noncontrolling interests
 
352

 
621

Net income attributable to Stericycle, Inc.
 
$
10,448

 
$
11,696

 
 
 
 
 
Depreciation and amortization
 
$
11,423

 
$
10,659


NOTE 13 – RESTRUCTURING CHARGES
During the first quarter of 2015, management began executing a realignment of our operations to reduce labor redundancies and facility costs. As part of this realignment, the Company recorded charges related to severance, fixed asset impairments, write-off of intangible assets, and recognition of lease expense for properties no longer used but for which we have a contractual obligation. The recorded restructuring liabilities are expected to be paid primarily within the current year. While the Company believes the recorded restructuring liabilities are adequate, revisions to current estimates may be recorded in future periods based on new information as it becomes available. There could be additional initiatives in the future to further streamline our operations. As such, the Company expects further expenses related to workforce reductions and other facility rationalization costs when those restructuring plans are finalized and related expenses are estimable.
The following table below highlights $12.3 million pre-tax charges for the quarter ended March 31, 2015, which are reflected as part of SG&A on our Condensed Consolidated Statements of Income.

18


In thousands
 
 
United States
 
International
 
Total Charges to Income
Employee severance and related costs
 
$
1,736

 
$
2,229

 
$
3,965

Other costs
 
1,458

 
704

 
2,162

Non-cash items:
 
 
 
 
 
 
Fixed assets impairment
 
3,133

 

 
3,133

Intangible assets impairment
 
2,167

 
247

 
2,414

Other
 

 
628

 
628

Total pre-tax restructuring expenses
 
$
8,494

 
$
3,808

 
$
12,302

The following table summarizes restructuring activity during 2015 which is reflected in the Condensed Consolidated Balance Sheets as part of "Accrued liabilities":
In thousands
 
 
Employee Severance and Related Costs
 
Other Costs
 
Total
Liability balance at January 1, 2015
 
$

 
$

 
$

Charges to income
 
3,965

 
2,162

 
6,127

Payments
 
(1,057
)
 
(735
)
 
(1,792
)
Other
 
(24
)
 

 
(24
)
Liability balance at March 31, 2015
 
$
2,884

 
$
1,427

 
$
4,311

NOTE 14 – LEGAL PROCEEDINGS
We operate in a highly regulated industry and must deal with regulatory inquiries or investigations from time to time that may be instituted for a variety of reasons. We are also involved in a variety of civil litigation from time to time.
Class Action Lawsuits. As we have previously disclosed, we were served on March 12, 2013 with a class action complaint filed in the U.S. District Court for the Western District of Pennsylvania by an individual plaintiff for itself and on behalf of all other "similarly situated" customers of ours. The complaint alleges, among other things, that we imposed unauthorized or excessive price increases and other charges on our customers in breach of our contracts and in violation of the Illinois Consumer Fraud and Deceptive Business Practices Act. The complaint sought certification of the lawsuit as a class action and the award to class members of appropriate damages and injunctive relief.
The Pennsylvania class action complaint was filed in the wake of a settlement with the State of New York of an investigation under the New York False Claims Act (which the class action complaint describes at some length). The New York investigation arose out of a qui tam (or "whistle blower") complaint under the federal False Claims Act and comparable state statutes which was filed under seal in the U.S. District Court for the Northern District of Illinois in April 2008 by a former employee of ours. The qui tam complaint was filed on behalf of the United States and 14 states and the District of Columbia. On September 4, 2013, we filed our answer to Plaintiff-Relator’s Second Amended Complaint, generally denying the allegations therein. Also, as previously disclosed, Tennessee, Massachusetts, Virginia and North Carolina have issued

19


civil investigative demands to explore the allegations made on their behalf in the qui tam complaint but have not yet decided whether to join the Illinois action. The qui tam case is in the early stages of discovery.
Following the filing of the Pennsylvania class action complaint, we were served with class action complaints filed in federal court in California, Florida, Illinois, Mississippi and Utah and in state court in California. These complaints asserted claims and allegations substantially similar to those made in the Pennsylvania class action complaint. All of these cases appear to be follow-on litigation to our settlement with the State of New York. On August 9, 2013, the Judicial Panel on Multidistrict Litigation (MDL) granted our Motion to Transfer these related actions to the Northern District of Illinois for centralized pretrial proceedings. On December 10, 2013, we filed our answer to the Amended Consolidated Class Action Complaint in the MDL action, generally denying the allegations therein. The MDL action is in the early stages of discovery.
We believe that we have operated in accordance with the terms of our customer contracts and that these complaints are without merit. We intend to vigorously defend ourselves against each of these lawsuits.
We have not accrued any amounts in respect of these lawsuits, and we cannot estimate the reasonably possible loss or the range of reasonably possible losses that we may incur. We are unable to make such an estimate because (i) litigation is by its nature uncertain and unpredictable, (ii) the proceedings are at an early stage and (iii) in our judgment, there are no comparable proceedings against other defendants that might provide guidance in making estimates.
Utah Proceedings. As previously disclosed, on December 3, 2014, we entered into an administrative settlement order (the "Settlement") with the State of Utah Division of Air Quality (the "DAQ") concerning a notice of violation and order to comply issued by the DAQ on May 28, 2013 and superseded by an amended notice of violation and order to comply issued on August 28, 2013 (the "NOV"). Under the Settlement, without admitting to any of the allegations contained in the NOV, we agreed to pay a civil penalty of $2.3 million, of which half, or $1.2 million , was paid within 30 days after December 3, 2014. The remaining $1.2 million will not be paid but instead will be credited to us as a Supplemental Environmental Project credit when we permanently close our North Salt Lake incineration facility which is required to occur no later than three years after we receive all permits and approvals necessary to commence construction of a new incineration facility to be located in Tooele County, Utah. The Settlement provides full and final resolution of any and all claims under the authority of the DAQ arising out of the allegations contained in the NOV and cannot be used by other parties to allege violations or negligence on our part in any other litigation or proceeding.
Junk Fax Lawsuit. On April 2, 2014, we were served with a class action complaint filed in the U.S. District Court for the Northern District of Illinois (Case 1:14-cv-02070) by an individual plaintiff for himself and on behalf of all other "similarly situated" persons. The complaint alleges, among other things, that we sent facsimile transmissions of unsolicited advertisements to plaintiff and others similarly situated in violation of the Telephone Consumer Protection Act of 1991, as amended by the Junk Fax Prevention Act of 2005 (the "TCPA"). The complaint seeks certification of the lawsuit as a class action and the award to class members of the greater of actual damages or the sum of $500 for each violation and injunctive and other relief. Under the TCPA, the statutory remedy of $500 per violation may be trebled if the Court finds the violations to be willful or knowing. On May 22, 2014, we filed our answer to the complaint, generally denying the allegations therein. Discovery in the case is proceeding.

20


We have not accrued any amounts in respect of the TCPA action, and we cannot estimate the reasonably possible loss or the range of reasonably possible losses that we may incur. We are unable to make such an estimate because (i) the proceedings are at an early stage and discovery is ongoing and (ii) other reported TCPA claims have resulted in a broad range of outcomes, with each case being dependent on its own unique facts and circumstances.
We review all of our outstanding legal proceedings with counsel quarterly, and we will disclose an estimate of any reasonably possible loss or range of reasonably possible losses if and when we are able to make such an estimate and the reasonably possible loss or range of reasonably possible losses is material to our financial statements.
Environmental Matters. On April 22, 2014, we completed our acquisition of PSC Environmental Services, LLC ("PSC Environmental") and consequently became subject to the legal proceedings in which PSC Environmental was a party on that date. PSC Environmental’s operations are regulated by federal, state and local laws enacted to regulate the discharge of materials into the environment, remediate contaminated soil and groundwater or otherwise protect the environment. As a result of this continuing regulation, PSC Environmental frequently becomes a party to legal or administrative proceedings involving various governmental authorities and other interested parties. The issues involved in these proceedings generally relate to alleged violations of existing permits and licenses or alleged responsibility under federal or state Superfund laws to remediate contamination at properties owned either by PSC Environmental or by other parties to which either PSC Environmental or the prior owners of certain of its facilities shipped wastes.
From time to time, PSC Environmental pays fines or penalties in regulatory proceedings relating primarily to waste treatment, storage or disposal facilities. We believe that the fines or other penalties that PSC Environmental may pay in connection with any pending regulatory proceedings of this nature will not, individually or in the aggregate, be material to our financial statements.
On September 18, 2014, our wholly-owned subsidiary, Stericycle Specialty Waste Solutions, Inc., received a notice of violation ("NOV") from the New Mexico Environment Department ("NMED") concerning our 10-day transfer facility in Albuquerque. The violations alleged in the NOV generally relate to the management of Conditionally Exempt Small Quantity Generator ("CESQG") waste under a CESQG agreement that we have with NMED, as well as some recordkeeping matters. We have met with NMED and are currently in discussions regarding a resolution of the matters alleged in the NOV. We believe that the penalties ultimately assessed under the NOV could exceed $100,000 but that, in any event, they will not be material to our financial statements.
NOTE 15 – SUBSEQUENT EVENT
 The Company evaluated subsequent events through the date of filing this Quarterly Report on Form 10-Q.
On April 30, 2015, we entered into a note purchase agreement with several institutional purchasers pursuant to which we will issue and sell to the purchasers $200.0 million of our new 2.67% seven-year unsecured senior notes (the "Series A notes") and $100.0 million of our new eight-year 2.74% unsecured senior notes (the "Series B notes").

21


Interest will be payable in arrears semi-annually on January 1, and July 1, beginning on January 1, 2016. The principal of the Series A notes will be payable at the maturity of the notes on July 1, 2022, and the principal of the Series B notes will be payable at the maturity of the notes on July 1, 2023. The notes will be unsecured obligations.
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
We are in the business of providing regulated and compliance solutions to healthcare and commercial businesses. This includes the collection and processing of specialized waste for disposal, and a variety of training, consulting, recall/return, communication, and compliance services. We were incorporated in 1989 and presently serve a diverse customer base of more than 604,000 customers throughout the United States, Argentina, Brazil, Canada, Chile, Ireland, Japan, Mexico, Portugal, Romania, Republic of Korea, Spain, and the United Kingdom.
The regulated solutions we provide include: medical waste disposal, our Steri-Safe® medical waste and compliance program, our Clinical Services program, our Sharps Management Service featuring Bio Systems® reusable sharps containers, pharmaceutical waste disposal, and hazardous waste disposal. Our compliance solutions include: training, consulting, inbound/outbound communications, data reporting, and other regulatory compliance services. In addition to our regulated and compliance solutions, we offer regulated recall and returns management solutions which encompass a number of services for a variety of businesses, but consist primarily of managing the recall, withdrawal, or return of expired or recalled products and pharmaceuticals.
There were no material changes in the Company’s critical accounting policies since the filing of its 2014 Form 10-K. As discussed in the 2014 Form 10-K, the preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States requires management to make certain estimates and assumptions that affect the amount of reported assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and revenues and expenses during the periods reported. Actual results may differ from those estimates.
Highlights of the three months ended March 31, 2015:
revenues were $663.3 million, up $93.4 million or 16.4% from $570.0 million in the first quarter last year;
first quarter gross profit as a percent of revenues decreased to 42.4% from 44.8% in 2014;
operating income was $127.1 million, down $5.6 million or 4.2% from $132.7 million in the first quarter last year;
we incurred $25.9 million in pre-tax expenses related to acquisitions, integration expense related to acquisitions, restructuring expense, litigation expenses, partially offset by change in fair value of contingent consideration;
cash flow from operations was $132.6 million.



22


THREE MONTHS ENDED MARCH 31, 2015 COMPARED TO
THREE MONTHS ENDED MARCH 31, 2014
The following summarizes the Company’s operations:
In thousands, except per share data
 
Three Months Ended March 31,
 
2015
 
2014
 
$
 
%
 
$
 
%
Revenues
$
663,319

 
100.0

 
$
569,955

 
100.0
Cost of revenues
367,340

 
55.4

 
301,186

 
52.8
Depreciation - cost of revenues
14,648

 
2.2

 
12,726

 
2.2
Plant conversion expenses

 

 
574

 
0.1
Total cost of revenues
381,988

 
57.6

 
314,486

 
55.2
Gross profit
281,331

 
42.4

 
255,469

 
44.8
Selling, general and administrative expenses (exclusive of adjusting items shown below)
115,431

 
17.4

 
100,180

 
17.6
Acquisition expenses
3,296

 
0.5

 
3,221

 
0.6
Integration expenses
8,886

 
1.3

 
2,485

 
0.4
Change in fair value of contingent consideration
(675
)
 
(0.1
)
 
4,789

 
0.8
Restructuring expenses
12,302

 
1.9

 

 
0.0
Litigation expenses
2,123

 
0.3

 
1,505

 
0.3
Total SG&A expenses (exclusive of depreciation and amortization shown below)
141,363

 
21.3

 
112,180

 
19.7
Depreciation
4,118

 
0.6

 
3,315

 
0.6
Amortization
8,797

 
1.3

 
7,315

 
1.3
Income from operations
127,053

 
19.2

 
132,659

 
23.3
Net interest expense
18,598

 
2.8

 
14,898

 
2.6
Other expense, net
598

 
0.1

 
700

 
0.1
Income tax expense
32,047

 
4.8

 
37,291

 
6.5
Net income
75,810

 
11.4

 
79,770

 
14.0
Less: net income attributable to noncontrolling interests
352

 
0.1

 
621

 
0.1
Net income attributable to Stericycle, Inc.
$
75,458

 
11.4

 
$
79,149

 
13.9
Earnings per share- diluted
$
0.87

 
 
 
$
0.91

 
 
Revenues: Our revenues increased $93.4 million, or 16.4%, in the first quarter of 2015 to $663.3 million from $570.0 million in the same period in 2014. Domestic revenues increased $82.5 million, or 21.2%, to $472.2 million from $389.8 million in the same period in 2014. Organic revenue growth for domestic small account customers increased by $17.2 million, or approximately 7.6%, driven by higher revenues from our Steri-Safe and regulated waste services for retailers. Organic revenue from domestic large account customers increased by $6.4 million, or approximately 4.6%, as we increased the total number of accounts and expanded our reusable sharps services and pharmaceutical waste disposal programs as well as strong performance in our specialty waste services. Organic revenues for recall and returns management services decreased by $6.9 million in 2015. Although our recall and returns management services had an overall increase in the number of recall events, there were fewer large scale events. Organic revenues exclude revenue growth attributed to businesses acquired within the preceding twelve months. Revenues from domestic acquisitions closed within the preceding twelve months contributed $65.8 million to the increase in revenues in the first quarter of 2015.

23


International revenues increased $10.9 million, or 6.0%, in the first quarter of 2015, to $191.1 million from $180.2 million in the same period in 2014. Organic growth, currency rate fluctuations and acquisitions impact the comparison of 2015 and 2014. Organic growth in the international segment contributed $13.5 million in revenues, or approximately 7.5%. Organic growth excludes the effect of foreign exchange and acquisitions and divestitures less than one year old. The effect of foreign exchange rates unfavorably impacted international revenues in 2015 by $23.1 million as foreign currencies declined against the U.S. dollar. Revenue from international acquisitions closed within the preceding twelve months contributed $20.5 million to the increase in revenues in the first quarter of 2015.
Cost of Revenues: Our cost of revenues increased $67.5 million, or 21.5%, in the first quarter of 2015 to $382.0 million from $314.5 million in the same period in 2014. We recognized $0.6 million in plant conversion expenses during the first quarter 2014.
Our domestic cost of revenues increased $57.5 million, or 29.5%, in the first quarter of 2015 to $252.3 million from $194.8 million in the same period in 2014 as a result of costs related to a proportional increase in revenues from acquisitions and internal growth. In addition, unusually severe weather negatively impacted our domestic cost of revenues.
Our international cost of revenues increased $10.0 million, or 8.4%, in the first quarter of 2015 to $129.7 million from $119.7 million in the same period in 2014 as a result of costs related to proportional increase in revenues from acquisitions and internal growth.
Our consolidated gross profit as a percent of revenues decreased to 42.4% during the first quarter of 2015 from 44.8% during the same period in 2014. In general, international gross profits are lower than domestic gross profits because international operations have fewer small account customers, which tend to provide higher gross profits. Historically, the international operations have had most of their revenues from large account customers, such as hospitals. As the international revenues increase, consolidated gross profits receive downward pressure due to this "business mix" shift, which may be offset by additional international small account market penetration, integration savings, and domestic business expansion.
Domestic gross profit as a percent of revenues decreased to 46.6% during the first quarter of 2015 from 50.0% in the same period in 2014 primarily due to the inclusion of the PSC Environmental acquisition results and unusually severe weather in 2015. International gross profit as a percent of revenues decreased to 32.1% during the first quarter of 2015 from 33.6% during the same period in 2014 due to service mix shift on new revenues.
Selling, General and Administrative Expenses: Excluding the effect of acquisition and integration expenses, and other items (collectively the "Adjusting Items"), depreciation, and amortization expenses, our selling, general and administrative ("SG&A") expenses increased $15.2 million, or 15.2%, in the first quarter of 2015 to $115.4 million from $100.2 million in the same period in 2014 primarily as investment spending supported the increase in revenues. As a percent of revenues, these costs decreased to 17.4% in the first quarter of 2015 from 17.6% during the same period in 2014.
Domestically, first quarter SG&A expenses, excluding Adjusting Items, depreciation, and amortization expenses, increased $9.9 million, or 14.4%, to $78.5 million from $68.6 million in the same period in 2014. As a percent of revenues, SG&A was at 16.6% in the first quarter of 2015 and 17.6% in the same period in 2014. As a percent of revenues, amortization expense of acquired intangible assets increased by 0.1%.
Internationally, first quarter SG&A expenses, excluding Adjusting Items, depreciation, and amortization expenses, increased $5.3 million, or 16.8%, to $36.9 million from $31.6 million in the same period in 2014. As a percent of revenues, SG&A was at 19.3% in the first quarter of 2015 compared to 17.5%

24


in the same period in 2014 in support of new business growth opportunities. As a percent of revenues, amortization expense of acquired intangible assets increased by 0.1%.
During the quarter ended March 31, 2015, we recognized $3.3 million in acquisition expenses, $8.9 million of expenses related to the integration of our acquisitions, $12.3 million in restructuring expenses (see Note 13 - Restructuring Charges in the Notes to the Condensed Consolidated Financial Statements), $2.1 million in litigation expenses, partially offset by a $0.7 million gain related to a change in the fair value of contingent consideration.
During the quarter ended March 31, 2014, we recognized $3.2 million in acquisition expenses, $2.5 million of expenses related to the integration of our acquisitions, $4.8 million related to a change in the fair value of contingent consideration, and $1.5 million in litigation expenses.
Income from Operations: Income from operations decreased $5.6 million, or 4.2%, in the first quarter of 2015 to $127.1 million from $132.7 million in same period in 2014. Comparison of income from operations between the first quarter of 2015 and the same period of 2014 was affected by Adjusting Items described above in the SG&A section.
Domestically, our income from operations decreased $0.5 million, or 0.4%, to $115.1 million in the first quarter of 2015 from $115.6 million in the same period in 2014. Internationally, our income from operations decreased $5.1 million, or 29.8%, to $12.0 million in the first quarter of 2015 from $17.1 million in the same period in 2014 primarily related to increased acquisition and integration expenses.
During the first quarter of 2015, management began executing a realignment of our operations to reduce labor redundancies and facility costs. As part of this realignment, the Company recorded charges related to severance, fixed asset impairments, write-off of intangible assets, and recognition of lease expense for properties no longer used but for which we have a contractual obligation.
Net Interest Expense: Net interest expense increased to $18.6 million during the first quarter of 2015 from $14.9 million during the same period in 2014. The increase in interest expense was due to increased borrowings and higher interest costs in Latin America.
Income Tax Expense: Income tax expense decreased to $32.0 million in the first quarter of 2015 from $37.3 million in the same period in 2014. The reported tax rates for the quarters ended March 31, 2015 and 2014 were 29.7% and 31.9%, respectively. The decrease in the current quarter tax rate is primarily related to a benefit from the recognition of tax deductible goodwill associated with legal entity mergers in Spain and Brazil.
LIQUIDITY AND CAPITAL RESOURCES
Our $1.2 billion senior credit facility maturing in June 2019, our $250.0 million term loan maturing in July 2015, our $100.0 million private placement notes maturing April 2015, our $175.0 million private placement notes maturing in October 2017, our $125.0 million private placement notes maturing in December 2019, our $225.0 million private placement notes maturing in October 2020, and our $125.0 million private placement notes maturing in December 2022, all require us to comply with various financial, reporting and other covenants and restrictions, including a restriction on dividend payments. The financial debt covenants are the same for the senior credit facility and the private placement notes. At March 31, 2015, we were in compliance with all of our financial debt covenants.
As of March 31, 2015, we had $175.6 million of borrowings outstanding under our $1.2 billion senior unsecured credit facility, which includes foreign currency borrowings of $75.6 million. We also had $157.7

25


million committed to outstanding letters of credit under this facility. The unused portion of the revolving credit facility as of March 31, 2015 was $866.7 million. At March 31, 2015, our interest rates on borrowings under our revolving credit facility were as follows:

A fee of 0.125% on our revolving credit facility
For borrowings less than one month, the higher of the following
Federal funds rate plus 0.5%
Euro Currency rate plus 1.0% or the prime rate
For borrowings greater than one month: LIBOR plus 1.0%
The weighted average rate of interest on the unsecured revolving credit facility was 1.72% per annum, which includes the 0.125% facility fee at March 31, 2015.
Our $250.0 million term loan matures in July 2015.
As of March 31, 2015, we had outstanding $100.0 million of seven-year 5.64% unsecured senior notes issued to nine institutional purchasers in a private placement completed in April 2008. Interest is payable in arrears semi-annually on April 15 and October 15 beginning on October 15, 2009, and principal is payable at the maturity of the notes on April 15, 2015. These notes have been classified as long-term debt due to our intent to pay this obligation by borrowing on our $1.2 billion senior credit facility.
As of March 31, 2015, we had outstanding $175.0 million of seven-year 3.89% unsecured senior notes and $225.0 million of 10-year 4.47% unsecured senior notes issued to 39 institutional purchasers in a private placement completed in October 2010. Interest is payable in arrears semi-annually on April 15 and October 15 beginning on April 15, 2011, and principal is payable at the maturity of the notes, October 15, 2017 in the case of the seven-year notes and October 15, 2020 in the case of the 10-year notes.
As of March 31, 2015, we had outstanding $125.0 million of seven-year 2.68% unsecured senior notes and $125.0 million of 10-year 3.26% unsecured senior notes issued to 46 institutional purchasers in a private placement completed in December 2012. Interest is payable in arrears semi-annually on June 12 and December 12 beginning on June 12, 2013, and principal is payable at the maturity of the notes, December 12, 2019 in the case of the seven-year notes and December 12, 2022 in the case of the 10-year notes.
As of March 31, 2015, we had $274.8 million in promissory notes issued in connection with acquisitions during 2007 through 2014, $117.6 million in foreign subsidiary bank debt outstanding, and $7.4 million in capital lease obligations.
Working Capital: At March 31, 2015, our working capital decreased $5.0 million to $113.7 million compared to $118.7 million at December 31, 2014.
Current assets increased by $15.8 million, mainly driven by $16.0 million increase in cash and cash equivalents due to high collections at the end of March. Days sales outstanding ("DSO") was calculated at 63 days at March 31, 2015 and 63 days at December 31, 2014.
Current liabilities increased by $20.9 million, primarily related to an increase in accrued liabilities, contingent consideration from new acquisitions and accounts payable, offset by a decrease in the current portion of foreign bank debt. We recapitalized our Latin America subsidiaries to pay down high interest local bank debt.
Net Cash Provided or Used: Net cash provided by operating activities decreased $13.3 million, or 9.1%, to $132.6 million during the three months ended March 31, 2015 compared to $145.8 million for the comparable period in 2014. Cash provided by operations as a ratio to net income was 175% and 183% for the three months ended March 31, 2015 and 2014, respectively.

26


Net cash used in investing activities for the three months ended March 31, 2015 was $55.3 million compared to $30.6 million in the same period in 2014. We used $21.9 million more in funds to acquire new businesses in 2015 compare to the same period of 2014. Our capital expenditures, as a percent of revenues, were at 3.2% and 2.9% in 2015 and 2014, respectively.
Net cash used in financing activities was $57.6 million during the three months ended March 31, 2015 compared to $132.8 million in the same period in 2014. We had share repurchases of $11.5 million in 2015 compared to $76.9 million in 2014, a decrease of $65.4 million.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
We are subject to market risks arising from changes in interest rates. Our potential additional interest expense over one year that would result from a hypothetical, instantaneous and unfavorable change of 100 basis points in the interest rate on all of our variable rate obligations would be approximately $5.8 million on a pre-tax basis.
We have exposure to commodity pricing for gas and diesel fuel for our trucks and for the purchase of containers and boxes. We do not hedge these items to manage the exposure.
We have exposure to foreign currency fluctuations. We have subsidiaries in twelve foreign countries whose functional currency is the local currency. Our international subsidiaries use local currency denominated lines of credit for their funding needs which is has no exposure to currency fluctuations. We translate results of operations of our international operations using an average exchange rate. Changes in foreign currency exchange rates could unfavorably impact our consolidated results of operations.

ITEM 4. CONTROLS AND PROCEDURES

Disclosure Controls and Procedures
Our management, with the participation of our President and Chief Executive Officer and our Chief Financial Officer, conducted an evaluation of the effectiveness of our disclosure controls and procedures as of the end of the fiscal quarter covered by this Report. On the basis of this evaluation, our President and Chief Executive Officer and our Chief Financial Officer each concluded that our disclosure controls and procedures were effective.
The term "disclosure controls and procedures" is defined in Rule 13a-15(e) of the Securities Exchange Act of 1934 as "controls and other procedures designed to ensure that information required to be disclosed by the issuer in the reports, files or submits under the Act is recorded, processed, summarized and reported, within the time periods specified in the Securities and Exchange Commission’s rules and forms." Our disclosure controls and procedures are designed to ensure that material information relating to us and our consolidated subsidiaries is accumulated and communicated to our management, including our President and Chief Executive Officer and our Chief Financial Officer, as appropriate to allow timely decisions regarding our required disclosures.


27


Internal Control Over Financial Reporting
The term internal control over financial reporting is defined as a process designed by, or under the supervision of, the issuers’ principal executive and principal financial officers, and effected by the issuer’s Board of Directors, management, and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. During the quarter ended March 31, 2015, there were no changes in our internal controls over financial reporting that have materially affected, or are reasonably likely to materially affect, our internal controls over financial reporting.
During 2014, we completed the acquisition of PSC Environmental Services, LLC (“PSC Environmental”). As of March 31, 2015, we were in the process of integrating PSC Environmental’s processes and related internal controls into our overall assessment of internal control over financial reporting. As permitted, our assessment of internal control over financial reporting did not include PSC Environmental.  During the quarter ended March 31, 2015, there were no changes in our internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.




FROM TIME TO TIME WE ISSUE FORWARD-LOOKING STATEMENTS RELATING TO SUCH THINGS AS ANTICIPATED FINANCIAL PERFORMANCE, BUSINESS PROSPECTS, ACQUISITION ACTIVITIES AND SIMILAR MATTERS.
THESE FORWARD-LOOKING STATEMENTS MAY INVOLVE RISKS AND UNCERTAINTIES, SOME OF WHICH ARE BEYOND OUR CONTROL (FOR EXAMPLE, GENERAL ECONOMIC CONDITIONS). OUR ACTUAL RESULTS COULD DIFFER SIGNIFICANTLY FROM THE RESULTS DESCRIBED IN THE FORWARD-LOOKING STATEMENTS. FACTORS THAT COULD CAUSE SUCH DIFFERENCES INCLUDE DIFFICULTIES IN COMPLETING THE INTEGRATION OF ACQUIRED BUSINESSES, CHANGES IN GOVERNMENTAL REGULATION OF MEDICAL WASTE COLLECTION AND TREATMENT, AND INCREASES IN TRANSPORTATION AND OTHER OPERATING COSTS, AS WELL AS VARIOUS OTHER FACTORS.


28


PART II. – OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS
See Note 14 - Legal Proceedings, in the Notes to the Condensed Consolidated Financial Statements (Item 1 of Part I).
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

Under resolutions that our Board of Directors has adopted, we have been authorized to purchase a cumulative total of 24,621,640 shares of our common stock on the open market. As of March 31, 2015, we had purchased a cumulative total of 19,987,168 shares.

The following table provides information about our purchases of shares of our common stock during the three months ended March 31, 2015:
Issuer Purchase of Equity Securities
Period
 
Total Number of Share (or Units) Purchased *
 
Average Price Paid per Share (or Unit)
 
Total Number of Shares (or Units) Purchased as Part of Publicly Announced Plans or Programs
 
Maximum Number of Shares (or Units) that May Yet Be Purchased Under the Plans or Programs
January 1 - January 31, 2015
 

 
$

 

 
4,735,185

February 1 - February 28, 2015
 

 

 

 
4,735,185

March 1 - March 31, 2015
 
100,713

 
136.74

 
100,713

 
4,634,472


29


ITEM 6. EXHIBITS

31.1
Rules 13a-14(a)/15d-14(a) Certification of Charles A. Alutto, President and Chief Executive Officer
 
 
31.2
Rule 13a-14(a)/15d-14(a) Certification of Daniel V. Ginnetti, Executive Vice President and Chief Financial Officer
 
 
32
Section 1350 Certification of Charles A. Alutto, President and Chief Executive Officer, and Daniel V. Ginnetti, Executive Vice President and Chief Financial Officer

101.INS XBRL
Instance Document
 
 
101.SCH XBRL
Taxonomy Extension Schema Document
 
 
101.CAL XBRL
Taxonomy Extension Calculation Linkbase Document
 
 
101.DEF XBRL
Taxonomy Definition Linkbase Document
 
 
101.LAB XBRL
Taxonomy Extension Label Linkbase Document
 
 
101.PRE XBRL
Taxonomy Extension Presentation Linkbase Document

30


SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Dated: May 7, 2015

                        
STERICYCLE, INC.
(Registrant)
By: /s/ DANIEL V. GINNETTI
Daniel V. Ginnetti
Executive Vice President and Chief Financial Officer (Principal Financial and Accounting Officer)


31
EX-31.1 2 srcl-20150331xex311.htm EXHIBIT 31.1 SRCL - 2015.03.31-EX31.1


Exhibit 31.1
Rule 13a-14(a)/15d-14(a) Certification
Charles A. Alutto
President and Chief Executive Officer

I, Charles A. Alutto, certify that:

1.
I have reviewed this quarterly report on Form 10-Q of Stericycle, Inc.;

2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and






5.
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b)
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 7, 2015

 
/s/ CHARLES A. ALUTTO
Charles A. Alutto
President and Chief
Executive Officer
Stericycle, Inc.




EX-31.2 3 srcl-20150331xex312.htm EXHIBIT 31.2 SRCL-2015.03.31-EX31.2


Exhibit 31.2
Rule 13a-14(a)/15d-14(a) Certification
Daniel V. Ginnetti
Executive Vice President and Chief Financial Officer

I, Daniel V. Ginnetti, certify that:

1.
I have reviewed this quarterly report on Form 10-Q of Stericycle, Inc.;

2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and






5.
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b)
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 7, 2015

 
/s/ DANIEL V. GINNETTI
Daniel V. Ginnetti
Executive Vice President and
Chief Financial Officer
Stericycle, Inc.



EX-32 4 srcl-20150331xex32.htm EXHIBIT 32 SRCL-2015.03.31-EX32


Exhibit 32
SECTION 1350 CERTIFICATION
In reference to this quarterly report on Form 10-Q of Stericycle, Inc. we, Charles A. Alutto, President and Chief Executive Officer of the registrant, and Daniel V. Ginnetti, an Executive Vice President and the Chief Financial Officer of the registrant, certify as follows, pursuant to 18 U.S.C. § 1350 (as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002):

(a)
the report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and

(b)
the information contained in the report fairly presents, in all material respects, the financial condition and results of operations of the registrant.

Date: May 7, 2015

 
/s/ CHARLES A. ALUTTO
Charles A. Alutto
President and Chief
Executive Officer
Stericycle, Inc.
 
/s/ DANIEL V. GINNETTI
Daniel V. Ginnetti
Executive Vice President and
Chief Financial Officer
Stericycle, Inc.



EX-101.INS 5 srcl-20150331.xml XBRL INSTANCE DOCUMENT 0000861878 2015-01-01 2015-03-31 0000861878 2015-05-04 0000861878 2014-12-31 0000861878 2015-03-31 0000861878 2014-01-01 2014-03-31 0000861878 2014-03-31 0000861878 2013-12-31 0000861878 us-gaap:CommonStockMember 2014-01-01 2014-12-31 0000861878 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2014-01-01 2014-12-31 0000861878 us-gaap:CommonStockMember 2015-03-31 0000861878 us-gaap:CommonStockMember 2013-12-31 0000861878 us-gaap:AdditionalPaidInCapitalMember 2015-01-01 2015-03-31 0000861878 us-gaap:AdditionalPaidInCapitalMember 2014-01-01 2014-12-31 0000861878 us-gaap:CommonStockMember 2015-01-01 2015-03-31 0000861878 us-gaap:RetainedEarningsMember 2015-01-01 2015-03-31 0000861878 us-gaap:NoncontrollingInterestMember 2014-01-01 2014-12-31 0000861878 us-gaap:RetainedEarningsMember 2014-01-01 2014-12-31 0000861878 2014-01-01 2014-12-31 0000861878 us-gaap:NoncontrollingInterestMember 2015-03-31 0000861878 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2015-03-31 0000861878 us-gaap:NoncontrollingInterestMember 2013-12-31 0000861878 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2015-01-01 2015-03-31 0000861878 us-gaap:CommonStockMember 2014-12-31 0000861878 us-gaap:NoncontrollingInterestMember 2015-01-01 2015-03-31 0000861878 us-gaap:NoncontrollingInterestMember 2014-12-31 0000861878 us-gaap:RetainedEarningsMember 2014-12-31 0000861878 us-gaap:RetainedEarningsMember 2013-12-31 0000861878 us-gaap:AdditionalPaidInCapitalMember 2015-03-31 0000861878 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2013-12-31 0000861878 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2014-12-31 0000861878 us-gaap:AdditionalPaidInCapitalMember 2014-12-31 0000861878 us-gaap:RetainedEarningsMember 2015-03-31 0000861878 us-gaap:AdditionalPaidInCapitalMember 2013-12-31 0000861878 country:US 2015-01-01 2015-03-31 0000861878 country:KR 2015-01-01 2015-03-31 0000861878 country:ES 2015-01-01 2015-03-31 0000861878 country:BR 2015-01-01 2015-03-31 0000861878 country:IE 2015-01-01 2015-03-31 0000861878 country:RO 2015-01-01 2015-03-31 0000861878 country:MX 2015-01-01 2015-03-31 0000861878 srcl:RegulatedWasteandComplianceSolutionsMember srcl:InternationalMember country:ES 2015-01-01 2015-03-31 0000861878 srcl:RegulatedWasteandComplianceSolutionsMember srcl:InternationalMember country:BR 2015-03-31 0000861878 srcl:RegulatedWasteandComplianceSolutionsMember srcl:InternationalMember country:RO 2015-01-01 2015-03-31 0000861878 srcl:RegulatedWasteandComplianceSolutionsMember srcl:InternationalMember country:IE 2015-01-01 2015-03-31 0000861878 srcl:AcquisitionOneMember srcl:RegulatedWasteandComplianceSolutionsMember country:US 2015-01-01 2015-03-31 0000861878 srcl:AcquisitionsYear2015Member us-gaap:CustomerRelationshipsMember us-gaap:MinimumMember 2015-01-01 2015-03-31 0000861878 srcl:RegulatedWasteandComplianceSolutionsMember srcl:InternationalMember country:KR 2015-01-01 2015-03-31 0000861878 srcl:AcquisitionTwoMember srcl:RegulatedWasteandComplianceSolutionsMember country:US 2015-01-01 2015-03-31 0000861878 srcl:RegulatedWasteandComplianceSolutionsMember srcl:InternationalMember country:IE 2015-03-31 0000861878 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2015-01-01 2015-03-31 0000861878 srcl:RegulatedWasteandComplianceSolutionsMember srcl:InternationalMember country:BR 2015-01-01 2015-03-31 0000861878 srcl:RegulatedWasteandComplianceSolutionsMember srcl:InternationalMember country:MX 2015-01-01 2015-03-31 0000861878 srcl:InternationalMember 2015-01-01 2015-03-31 0000861878 country:US 2015-01-01 2015-03-31 0000861878 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2014-01-01 2014-03-31 0000861878 srcl:AcquisitionsYear2015Member us-gaap:CustomerRelationshipsMember 2015-01-01 2015-03-31 0000861878 srcl:AcquisitionsYear2015Member us-gaap:CustomerRelationshipsMember us-gaap:MaximumMember 2015-01-01 2015-03-31 0000861878 srcl:AcquisitionOneMember srcl:RegulatedWasteandComplianceSolutionsMember country:US 2015-03-31 0000861878 srcl:RegulatedWasteandComplianceSolutionsMember srcl:InternationalMember country:MX 2015-03-31 0000861878 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2014-03-31 0000861878 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2015-03-31 0000861878 us-gaap:FairValueInputsLevel2Member 2015-03-31 0000861878 2015-03-01 2015-03-31 0000861878 us-gaap:FairValueInputsLevel3Member us-gaap:OtherCurrentLiabilitiesMember 2015-03-31 0000861878 us-gaap:FairValueInputsLevel3Member 2014-12-31 0000861878 us-gaap:MaximumMember 2015-03-31 0000861878 us-gaap:FairValueInputsLevel3Member 2015-03-31 0000861878 us-gaap:FairValueInputsLevel2Member 2014-12-31 0000861878 us-gaap:FairValueInputsLevel1Member 2014-12-31 0000861878 us-gaap:FairValueInputsLevel1Member 2015-03-31 0000861878 us-gaap:RestrictedStockUnitsRSUMember us-gaap:MinimumMember 2015-01-01 2015-03-31 0000861878 us-gaap:RestrictedStockUnitsRSUMember us-gaap:MaximumMember 2015-01-01 2015-03-31 0000861878 us-gaap:RestrictedStockUnitsRSUMember 2015-01-01 2015-03-31 0000861878 us-gaap:RestrictedStockUnitsRSUMember 2015-03-31 0000861878 us-gaap:StockOptionMember 2015-03-31 0000861878 us-gaap:StockOptionMember 2015-01-01 2015-03-31 0000861878 us-gaap:StockOptionMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2015-01-01 2015-03-31 0000861878 us-gaap:StockOptionMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2014-01-01 2014-03-31 0000861878 us-gaap:RestrictedStockUnitsRSUMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2014-01-01 2014-03-31 0000861878 us-gaap:EmployeeStockMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2014-01-01 2014-03-31 0000861878 us-gaap:RestrictedStockUnitsRSUMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2015-01-01 2015-03-31 0000861878 us-gaap:StockOptionMember us-gaap:CostOfSalesMember 2014-01-01 2014-03-31 0000861878 us-gaap:StockOptionMember us-gaap:CostOfSalesMember 2015-01-01 2015-03-31 0000861878 us-gaap:EmployeeStockMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2015-01-01 2015-03-31 0000861878 country:US 2014-12-31 0000861878 srcl:InternationalMember 2014-01-01 2014-12-31 0000861878 srcl:InternationalMember 2014-12-31 0000861878 country:US 2013-12-31 0000861878 country:US 2015-03-31 0000861878 country:US 2014-01-01 2014-12-31 0000861878 srcl:InternationalMember 2013-12-31 0000861878 srcl:InternationalMember 2015-03-31 0000861878 us-gaap:NoncompeteAgreementsMember 2015-01-01 2015-03-31 0000861878 us-gaap:TradeNamesMember 2015-01-01 2015-03-31 0000861878 us-gaap:GoodwillMember srcl:InternationalMember country:PR 2015-01-01 2015-03-31 0000861878 us-gaap:NoncompeteAgreementsMember us-gaap:MinimumMember 2015-01-01 2015-03-31 0000861878 us-gaap:TechnologyBasedIntangibleAssetsMember us-gaap:MinimumMember 2015-01-01 2015-03-31 0000861878 us-gaap:CustomerRelationshipsMember 2015-01-01 2015-03-31 0000861878 us-gaap:TechnologyBasedIntangibleAssetsMember 2015-01-01 2015-03-31 0000861878 us-gaap:TradeNamesMember us-gaap:MaximumMember 2015-01-01 2015-03-31 0000861878 us-gaap:CustomerRelationshipsMember us-gaap:MinimumMember 2015-01-01 2015-03-31 0000861878 srcl:OperatingPermitsMember 2015-01-01 2015-03-31 0000861878 us-gaap:NoncompeteAgreementsMember us-gaap:MaximumMember 2015-01-01 2015-03-31 0000861878 us-gaap:TradeNamesMember us-gaap:MinimumMember 2015-01-01 2015-03-31 0000861878 us-gaap:CustomerRelationshipsMember us-gaap:MaximumMember 2015-01-01 2015-03-31 0000861878 srcl:AmortizableIntangibleAssetsMember us-gaap:NoncompeteAgreementsMember 2015-03-31 0000861878 srcl:AmortizableIntangibleAssetsMember us-gaap:CustomerRelationshipsMember 2015-03-31 0000861878 srcl:AmortizableIntangibleAssetsMember us-gaap:TechnologyBasedIntangibleAssetsMember 2015-03-31 0000861878 srcl:AmortizableIntangibleAssetsMember us-gaap:CustomerRelationshipsMember 2014-12-31 0000861878 srcl:AmortizableIntangibleAssetsMember us-gaap:NoncompeteAgreementsMember 2014-12-31 0000861878 srcl:AmortizableIntangibleAssetsMember us-gaap:TechnologyBasedIntangibleAssetsMember 2014-12-31 0000861878 srcl:AmortizableIntangibleAssetsMember us-gaap:TradeNamesMember 2014-12-31 0000861878 srcl:AmortizableIntangibleAssetsMember us-gaap:OtherIntangibleAssetsMember 2014-12-31 0000861878 us-gaap:IndefinitelivedIntangibleAssetsMember srcl:OperatingPermitsMember 2015-03-31 <